New Century Pharmaceuticals, Inc. is a biopharmaceutical company with an Oncology and Anti-infective focus which uses leading expertise.

Takeda Vaccines, Inc., a subsidiary of Takeda Pharmaceutical Co., Ltd., is an American company located in Bozeman, MT. The firm provides biological research and development services.

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C.

Hua Song (Shanghai) Biomedical Technology Co., Ltd., established on 2017-11-26, Business scope includes technical consultation in the field of biomedical technology,Technical Services,technology transfer,technology development,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer antibody discovery and development services to customers. BioInvent's business model and technology platform have been validated through numerous partnerships. These include a co-development agreement with Bayer, Daiichi Sankyo, Mitsubishi Tanabe, Servier and others. BioInvent employs around 50 people and is based in Lund, Sweden. The Company listed on the NASDAQ OMX Stockholm in 2001.

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

OBI Pharma, Inc. engages in the development and licensing of novel therapeutic agents for unmet medical needs against cancer. Its products include Adagloxad Simolenin, which is a late-stage novel active immune-oncology Globo Series-based therapeutic vaccine for the treatment of epithelial cancers, such as breast, ovarian, lung, prostate, colon, gastric, and pancreatic cancer. The company was founded by Michael N. Chang on April 29, 2002 and is headquartered in Taipei, Taiwan.

Shandong Renrui Biotechnology Co., Ltd., established on 2014-03-12, Business scope includes general items:Biochemical product technology research and development;Manufacturing of bio-based materials;Sales of bio-based materials;Cosmetics Wholesale;Cosmetics Retail;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Food detergent sales;Manufacturing of daily chemical products;Chemical product sales(No licensed chemical products);Conference and Exhibition Services;Graphic design and production;advertisement making;Advertising Design,acting;advertising;Office Supplies Sales;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals);Health food production;Production of food detergents;Veterinary drug production;Veterinary drug business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology.\nThe company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI.

Shanghai Fuhong Henlius Biopharmaceutical Co., Ltd., established on 2017-12-26, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Sales of Class I Medical Devices;Class II Medical Device Leasing;Machinery and Equipment Leasing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Queen Emma Land Co. operates as a not-for-profit organization. It provides real estate services. The company was founded on September 1, 1978 and is headquartered in Honolulu, HI.

Shanghai Zuolin Biotechnology Co., Ltd., established on 2021-12-22, Business scope includes licensed projects:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);translation service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales;Instrument sales;Chemical product sales(No licensed chemical products);Machinery sales;Import and export agency;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhan Institute of Biological Products Co., Ltd. is a Chinese company located in Wuhan and ultimately controlled by the Government of China that develops vaccines and immunization products.

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology. The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in 2009. It is headquartered in the Shanghai Caohejing High-Technology Park.

Shanghai Fuhong Henlius Biopharmaceutical Co., Ltd., established on 2014-06-26, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Specialty Chemicals Sales(Free of Hazardous Chemicals);Instrument sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)